Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.
French
R S
RS
Department of Sexually Transmitted Diseases, Royal Free and University College Medical School, London, UK.
Cowan
F M
FM
Mansour
D J
DJ
Morris
S
S
Procter
T
T
Hughes
D
D
Robinson
A
A
Guillebaud
J
J
D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis; D004343:Drug Implants / Q000191:economics; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007436:Intrauterine Devices, Medicated / Q000191:economics; D016912:Levonorgestrel / Q000008:administration & dosage* / Q000191:economics; D017060:Patient Satisfaction; D011247:Pregnancy; D011446:Prospective Studies; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel